TAM-derived CCL18 induces EMT in breast cancer and activates ERK and Akt/GSK-3β/Snail signaling in human umbilical vein endothelial cells, thereby contributing to its pro-angiogenic effect [118]. Here, AKT1 is linked to breast cancer.